Skip to main content
. 2020 Aug 14;17(16):5899. doi: 10.3390/ijerph17165899

Table 2.

Comparison between the Holden and Tinetti scale scores of the study participants pre- and postintervention.

TOTAL
Outcome variables Control (N = 23) Experimental (N = 23)
Preintervention, median (IQR) Postintervention, median (IQR) Difference U statistic p-value Pre-intervention, median (IQR) Postintervention, median (IQR) Difference U statistic p-value
Holden scale 10.0 (7.50; 16.5) 9.00 (6.00; 15.5) −1.00 (−2.00; 0.00) 10 0.004 * 13.0 (7.00; 18.0) 7.00 (3.50; 13.5) −3.00 (−5.00; −2.00) 0 <0.001 *
Tinetti scale
Total score 16.0 (13.0; 20.0) 18.0 (14.0; 22.0) 1.00 (1.00; 4.00) 171 <0.001 * 13.0 (9.00; 17.0) 17.0 (11.5; 19.0) 3.00 (2.00; 3.50) 231 <0.001 *
Gait score 6.00 (4.00; 9.00) 6.00 (4.50; 9.00) 0.00 (0.00; 0.50) 21 0.026 * 5.00 (3.00; 7.00) 6.00 (3.50; 7.50) 1.00 (0.00; 1.00) 85.5 0.004 *
Balance score 10.0 (9.00; 11.0) 11.0 (10.0; 13.0) 1.00 (1.00; 3.50) 171 <0.001 * 8.00 (5.50; 10.0) 10.0 (8.00; 12.0) 2.00 (1.00; 3.00) 253 <0.001 *
GDS 2–4
Control (N = 6) Experimental (N = 9)
Holden scale 6.5 (4.5; 8.5) 6 (4.5; 6.75) −1 (−1.75; −0.25) 0 0.098 7 (4; 9) 4 (2; 5) −3 (−6; −2) 0 0.009 *
Tinetti scale
Total score 14.5 (13.25; 18.75) 19 (16.5; 23.75) 4 (1.75; 4.75) 21 0.035 * 11 (8; 14) 16 (10; 18) 3 (2; 5) 45 0.009 *
Gait score 5.5 (4.25; 7.5) 6 (6; 8.25) 0.5 (0; 1) 6 0.174 3 (3; 6) 5 (4; 7) 1 (0; 1) 21 0.026 *
Balance score 9 (9; 11.25) 13 (10.5; 15.5) 3.5 (1.5; 4) 21 0.035 * 7 (5; 8) 10 (6; 11) 3 (1; 3) 45 0.009 *
GDS 5–6
Control (N = 17) Experimental (N = 14)
Holden scale 14 (9; 17) 14 (8; 16) −1 (−2; 0) 7.5 0.023 * 16.5 (9.25; 24.5) 13 (8; 19.25) −3.5 (−5; −2.25) 0 0.002 *
Tinetti scale
Total score 16 (13; 20) 17 (14; 21) 1 (0; 3) 78 0.002 * 15 (11; 18) 18 (14; 19.75) 3 (2; 3) 78 0.002 *
Gait score 7 (4; 9) 7 (4; 9) 0 (0; 0) 6 0.149 5.5 (3.25; 8.5) 6 (3.5; 8) 0 (0; 1) 25 0.065
Balance score 10 (8; 11) 11 (10; 12) 1 (0; 3) 78 0.002 * 9 (7; 10) 12 (9.25; 12) 2 (1; 3) 91 0.001 *

The effect observed in the CG and EG was observed at the end of the trial (postintervention) with respect to the corresponding value at baseline (preintervention). The difference was assessed by using a Mann–Whitney test for paired samples. *: p-value < 0.05.